Literature DB >> 20875378

Poor muscle quality rather than reduced lean body mass is responsible for the lower serum creatinine level in hemodialysis patients with diabetes mellitus.

M Inaba1, M Kurajoh, S Okuno, Y Imanishi, S Yamada, K Mori, E Ishimura, T Yamakawa, Y Nishizawa.   

Abstract

BACKGROUND: The serum creatinine level is significantly lower in well-nourished hemodialysis patients with diabetes mellitus (DM) than in their non-DM counterparts, despite the presence of anuria in these patients. The factors associated with this finding have not been determined. PATIENTS AND METHODS: We evaluated the association of serum creatinine with handgrip strength (HGS) and lean body mass index (LMI) in a cross-sectional study of 102 DM and 208 non-DM hemodialysis patients to determine if poorer muscle quality in DM patients could explain the reduced level of serum creatinine. All the DM patients were well-nourished. Grip dynamometry and dual-energy X-ray absorptiometry (DXA) were used to measure HGS and LMI, respectively.
RESULTS: The DM patients had a significantly lower serum creatinine level and HGS compared to the non-DM patients, but whole-body LMI and LMI of the upper limbs did not differ between the two groups of patients. The DM patients had significantly lower serum creatinine/whole-body LMI, serum creatinine/arm LMI, HGS/whole-body LMI, and HGS/arm LMI ratios. The serum creatinine level was significantly correlated with HGS and with whole-body and upper limb LMI in both groups of patients. However, regression analyses of LMI with serum creatinine and HGS gave significantly shallower slopes for the DM patients compared to the non-DM patients.
CONCLUSION: This suggests that the muscle strength generated per unit of muscle mass, which is reflected well by the serum creatinine level, is significantly reduced in DM hemodialysis patients. Therefore, our results show that the significantly lower serum creatinine levels in DM hemodialysis patients compared to non-DM hemodialysis patients may be explained by poor muscle quality rather than by reduced muscle mass or malnutrition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875378

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  13 in total

1.  Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation.

Authors:  E Todd Schroeder; Jiaxiu He; Kevin E Yarasheski; Ellen F Binder; Carmen Castaneda-Sceppa; Shalender Bhasin; Christina M Dieli-Conwright; Miwa Kawakubo; Ronenn Roubenoff; Stanley P Azen; Fred R Sattler
Journal:  Eur J Appl Physiol       Date:  2011-07-12       Impact factor: 3.078

Review 2.  Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition).

Authors:  Yoshiki Nishizawa; Hiroaki Ohta; Masakazu Miura; Masaaki Inaba; Schoichi Ichimura; Masataka Shiraki; Junichi Takada; Osamu Chaki; Hiroshi Hagino; Saeko Fujiwara; Masao Fukunaga; Takami Miki; Noriko Yoshimura
Journal:  J Bone Miner Metab       Date:  2012-11-10       Impact factor: 2.626

3.  Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent Differences.

Authors:  Sadi Loai; Xuetao Sun; Mansoor Husain; Michael A Laflamme; Herman Yeger; Sara S Nunes; Hai-Ling Margaret Cheng
Journal:  Front Cardiovasc Med       Date:  2022-05-18

4.  Exercise is associated with metabolism regulation and complications in Korean patients with type 2 diabetes.

Authors:  Jin-Won Noh; Jeong Eun Park; Jin Hee Jung; Jung Hwa Lee; Kang Hee Sim; Min Hee Kim
Journal:  J Phys Ther Sci       Date:  2015-07-22

5.  Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis.

Authors:  Katsuhito Mori; Kozo Nishide; Senji Okuno; Tetsuo Shoji; Masanori Emoto; Akihiro Tsuda; Shinya Nakatani; Yasuo Imanishi; Eiji Ishimura; Tomoyuki Yamakawa; Shigeichi Shoji; Masaaki Inaba
Journal:  BMC Nephrol       Date:  2019-03-28       Impact factor: 2.388

6.  Inverse association of plasma leptin with cortical thickness at distal radius determined with a quantitative ultrasound device in patients with type 2 diabetes mellitus.

Authors:  Masafumi Kurajoh; Masaaki Inaba; Koka Motoyama; Nagato Kuriyama; Etsuko Ozaki; Teruhide Koyama; Shinsuke Yamada; Tomoaki Morioka; Yasuo Imanishi; Masanori Emoto
Journal:  J Diabetes Investig       Date:  2019-06-05       Impact factor: 4.232

Review 7.  Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Especially Those Undergoing Hemodialysis.

Authors:  Katsuhito Mori
Journal:  Nutrients       Date:  2021-05-02       Impact factor: 5.717

8.  Evidence for the benefit of exercise therapy in patients with type 2 diabetes.

Authors:  Kenneth M Madden
Journal:  Diabetes Metab Syndr Obes       Date:  2013-07-03       Impact factor: 3.168

9.  Paradoxical positive association of serum adiponectin with all-cause mortality based on body composition in Japanese haemodialysis patients.

Authors:  Yuri Machiba; Masaaki Inaba; Katsuhito Mori; Masafumi Kurajoh; Kozo Nishide; Kyoko Norimine; Tomoyuki Yamakawa; Shigeichi Shoji; Senji Okuno
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

10.  Relation of Lean Body Mass and Muscle Performance to Serum Creatinine Concentration in Hemodialysis Patients.

Authors:  Janez Vodičar; Jernej Pajek; Vedran Hadžić; Maja Bučar Pajek
Journal:  Biomed Res Int       Date:  2018-06-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.